Repository hosted by TU Delft Library

Home · Contact · About · Disclaimer ·
 

Search results also available in MS Excel format.

Showing 1 to 11 of 11 found. | Sort by date

1 A joint latent class changepoint model to improve the prediction of time to graft failure
article 2008    
Author: Garre, F.G. · Zwinderman, A.H. · Geskus, R.B. · Sijpkens, Y.W.J.
Keywords: Health · Changepoint · Joint models · Kidney failure · Latent class · Predictions
[Abstract]

2 Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: Investigating differential effects among statins
article 2008    
Author: Bergheanu, S.C. · Reijmers, T. · Zwinderman, A.H. · Bobeldijk, I. · Ramaker, R. · Liem, A.-H. · Greef, J. van der · Hankemeier, T. · Jukema, J.W.
Keywords: Biology · Atorvastatin · Cardiovascular risk · Phosphatidylcholines · Rosuvastatin · Sphingomyelins · Atorvastatin · Cholesterol · High density lipoprotein cholesterol · Hydroxymethylglutaryl coenzyme A reductase inhibitor · Low density lipoprotein cholesterol · Phosphatidylcholine · Rosuvastatin · Sphingomyelin · Triacylglycerol · Adult · Aged · Article · Cardiovascular risk · Cholesterol blood level · Clinical trial · Controlled clinical trial · Controlled study · Coronary artery disease · Drug dose increase · Drug efficacy · Drug megadose · Female · Human · Lipid blood level · Lipid metabolism · Lipidomics · Liquid chromatography · Low drug dose · Major clinical study · Male · Mass spectrometry · Multicenter study · Phase 3 clinical trial · Randomized controlled trial · Therapy effect · Treatment outcome · Chromatography, Liquid · Dose-Response Relationship, Drug · Fluorobenzenes · Heptanoic Acids · Humans · Hydroxymethylglutaryl-CoA Reductase Inhibitors · Lipids · Mass Spectrometry · Prospective Studies · Pyrimidines · Pyrroles · Sulfonamides
[Abstract]

3 455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: Proposed role for an acute-phase reaction pattern of fibrinogen
article 1998    
Author: Maat, M.P.M. de · Kastelein, J.J.P. · Jukema, J.W. · Zwinderman, A.H. · Jansen, H. · Groenemeier, B. · Bruschke, A.V.G. · Kluft, C.
Keywords: Biology · Cardiovascular diseases · Fibrinogen · Genetics · Aged · Coronary Angiography · Coronary Arteriosclerosis · Disease Progression · Double-Blind Method · Fibrinogen · Genotype · Humans · Male · Middle Aged · Polymorphism, Genetic
[Abstract]

4 Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovascular events
article 2004    
Author: Boekholdt, S.M. · Peters, R.J.G. · Maat, M.P.M. de · Zwinderman, A.H. · Wall, E.E. van der · Reitsma, P.H. · Jukema, J.W. · Kastelein, J.J.P.
Keywords: fibrinogen receptor · glycoprotein IIIa · adult · angiography · cardiovascular risk · clinical trial · controlled clinical trial · controlled study · coronary artery atherosclerosis · DNA polymorphism · genetic risk · genetic variability · genotype · heterozygote · major clinical study · multicenter study · priority journal · randomized controlled trial · risk factor · survival · thrombocyte · Coronary Arteriosclerosis · Disease-Free Survival · Fibrinogen · Genotype · Humans · Integrin beta3 · Male · Middle Aged · Platelet Aggregation · Platelet Glycoprotein GPIIb-IIIa Complex · Polymorphism, Genetic · Pravastatin · Proportional Hazards Models · Receptors, Fibrinogen · Risk Assessment
[Abstract]

5 Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis—data from the RAPIT study : Concise Report
article 2008    
Author: Jong, Z. de · Munneke, M. · Vilim, V. · Zwinderman, A.H. · Kroon, H.M. · Ronday, H.K. · Lems, W.F. · Dijkmans, B.A.C. · Breedveld, F.C. · Vliet Vlieland, T.P.M. · Hazes, J.M.W. · Groot, J. de
Keywords: Biology Health · Biomedical Innovation · Healthy Living
[Abstract]

6 An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in men
article 2004    
Author: Agema, W.R.P. · Maat, M.P.M. de · Zwinderman, A.H. · Kastelein, J.J.P. · Rabelink, T.J. · Boven, A.J. van · Feskens, E.J.M. · Boer, J.M.A. · Wall, E.E. van der · Jukema, J.W.
Keywords: Biology · Biomedical Research · Atherosclerosis · Coronary artery disease · Endothelial constitutive nitric oxide synthase (ecNOS) · Genetic polymorphism · Endothelial nitric oxide synthase · Angiography · Cigarette smoking · Clinical trial · Controlled clinical trial · Controlled study · Disease course · Disease severity · DNA polymorphism · Enzyme polymorphism · Genetic association · Genotype · Heart infarction · Heart muscle ischemia · Major clinical study · Randomized controlled trial · ST segment · Anticholesteremic Agents · Case-Control Studies · Coronary Angiography · Coronary Disease · Disease Progression · Genetic Predisposition to Disease · Humans · Male · Middle Aged · Myocardial Infarction · Myocardial Ischemia · Nitric Oxide Synthase · Nitric Oxide Synthase Type III · Polymorphism, Genetic · Pravastatin · Statistics, Nonparametric
[Abstract]

7 Interleukin 10: A new risk marker for the development of restenosis after percutaneous coronary intervention
article 2007    
Author: Monraats, P.S. · Kurreeman, F.A.S. · Pons, D. · Sewgobind, V.D.K.D. · Vries, F.R. de · Zwinderman, A.H. · Maat, M.P.M. de · Doevendans, P.A. · Winter, R.J. de · Tio, R.A. · Waltenberger, J. · Huizinga, T.W.J. · Eefting, D. · Quax, P.H.A. · Frants, R.R. · Laarse, A. van der · Wall, E.E. van der · Jukema, J.W.
Keywords: Health · Biomedical Research · alanine · clopidogrel · cysteine · glycine · interleukin 10 · ticlopidine · adult · aged · article · cardiovascular risk · confidence interval · controlled study · coronary artery bypass graft · disease marker · DNA flanking region · DNA microarray · drug eluting stent · female · gene linkage disequilibrium · gene locus · genetic association · genetic polymorphism · genetic predisposition · genetic risk · genetic variability · genotype · heart infarction · human · hypothesis · in-stent restenosis · major clinical study · male · pathogenesis · percutaneous coronary intervention · priority journal · risk factor · 3' Untranslated Regions · Aged · Angioplasty, Transluminal, Percutaneous Coronary · Coronary Restenosis · Female · Genetic Predisposition to Disease · Genotype · Humans · Inflammation · Interleukin-10 · Male · Middle Aged · Polymorphism, Genetic · Promoter Regions (Genetics) · Prospective Studies · Risk Factors · Treatment Outcome
[Abstract]

8 The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions
article 2007    
Author: Pons, D. · Monraats, P.S. · Maat, M.P.M. de · Pires, N.M.M. · Quax, P.H.A. · Vlijmen, B.J.M. van · Rosendaal, F.R. · Zwinderman, A.H. · Doevendans, P.A.F.M. · Waltenberger, J. · Winter, R.J. de · Tio, R.A. · Frants, R.R. · Laarse, A. van der · Wall, E.E. van der · Jukema, J.W.
Keywords: Biology · Biomedical Research · Coagulation factors · Polymorphisms · Restenosis · Aged · Angioplasty, Transluminal, Percutaneous Coronary · Coronary Restenosis · Coronary Stenosis · Diabetes Complications · Factor V · Factor VII · Female · Follow-Up Studies · Genetic Predisposition to Disease · Hemostasis · Heterozygote · Homozygote · Humans · Male · Middle Aged · Netherlands · Phenotype · Plasminogen Activator Inhibitor 1 · Polymorphism, Genetic · Proportional Hazards Models · Prospective Studies · Prothrombin · Research Design · Risk Assessment · Risk Factors · Smoking · Time Factors · Treatment Outcome
[PDF] [Abstract]

9 Current PTCA practice and clinical outcomes in the Netherlands: The real world in the pre-drug-eluting stent era
article 2004    
Author: Agema, W.R.P. · Monraats, P.S. · Zwinderman, A.H. · Winter, R.J. de · Tio, R.A. · Doevendans, P.A.F.M. · Waltenberger, J. · Maat, M.P.M. de · Frants, R.R. · Atsma, D.E. · Laarse, A. van der · Wall, E.E. van der · Jukema, J.W.
Keywords: Biology · Biomedical Research · Percutaneous transluminal coronary angioplasty · Restenosis · acetylsalicylic acid · clopidogrel · fibrinogen receptor antagonist · ticlopidine · acute heart infarction · adult · aged · clinical trial · coronary artery bypass graft · diabetes mellitus · drug eluting stent · follow up · heart death · heart disease · hypertension · interventional cardiovascular procedure · major clinical study · multicenter study · peripheral vascular disease · practice guideline · restenosis · revascularization · risk factor · stable angina pectoris · transluminal coronary angioplasty · treatment outcome · Angioplasty, Transluminal, Percutaneous Coronary · Coronary Restenosis · Drug Implants · Female · Follow-Up Studies · Humans · Male · Middle Aged · Myocardial Revascularization · Netherlands · Professional Practice · Prospective Studies · Risk Factors · Stents · Treatment Outcome
[Abstract]

10 Genetic inflammatory factors predict restenosis after percutaneous coronary interventions
article 2005    
Author: Monraats, P.S. · Pires, N.M.M. · Agema, W.R.P. · Zwinderman, A.H. · Schepers, A. · Maat, M.P.M. de · Doevendans, P.A. · Winter, R.J. de · Tio, R.A. · Waltenberger, J. · Frants, R.R. · Quax, P.H.A. · Vlijmen, B.J.M. van · Atsma, D.E. · Laarse, A. van der · Wall, E.E. van der · Jukema, J.W.
Keywords: Biology · Biomedical Research · Angioplasty · Genetics · Restenosis · Risk factors · alanine · beta 2 adrenergic receptor · glycine · threonine · adult · aged · allele · Cd14 gene · colony stimulating factor 2 gene · controlled study · coronary artery disease · disease predisposition · eotaxin gene · female · gene identification · genetic polymorphism · genetic risk · haplotype · heart muscle revascularization · human · major clinical study · male · percutaneous coronary intervention · probability · prospective study · restenosis · risk assessment · risk factor · Amino Acid Substitution · Angioplasty, Transluminal, Percutaneous Coronary · Coronary Restenosis · Humans · Inflammation · Polymorphism, Single Nucleotide · Prospective Studies · Treatment Outcome
[Abstract]

11 Tumor necrosis factor-α plays an important role in restenosis development
article 2005    
Author: Monraats, P.S. · Pires, N.M.M. · Schepers, A. · Agema, W.R.P. · Boesten, L.S.M. · Vries, M.R. de · Zwinderman, A.H. · Maat, M.P.M. de · Doevendans, P.A.F.M. · Winter, R.J. de · Tio, R.A. · Waltenberger, J. · Hart, L.M. 't · Frants, R.R. · Quax, P.H.A. · Vlijmen, B.J.M. van · Havekes, L.M. · Laarse, A. van der · Wall, E.E. van der · Jukema, J.W.
Keywords: Biology Health · Biomedical Research · Haplotype · TNFα · Transgenic mice · Apolipoprotein E3 · Messenger RNA · Thalidomide · Tumor necrosis factor alpha · Adult · Aged · Angiography · Animal experiment · Animal model · Clinical practice · Disease marker · Drug delivery system · Genetic polymorphism · Heredity · Knockout mouse · Nonhuman · Percutaneous coronary intervention · Restenosis · Risk assessment · Screening · Aged · Alleles · Angina Pectoris · Angiography · Angioplasty, Transluminal, Percutaneous Coronary · Animals · Constriction, Pathologic · Coronary Angiography · Coronary Disease · Coronary Restenosis · Disease Models, Animal · Female · Femoral Artery · Gene Expression Regulation, Neoplastic · Genetic Predisposition to Disease · Genotype · Haplotypes · Humans · Inflammation · Ischemia · Linkage Disequilibrium · Male · Mice · Mice, Knockout · Mice, Transgenic · Middle Aged · Multivariate Analysis · Odds Ratio · Polymorphism, Genetic · Regression Analysis · Reverse Transcriptase Polymerase Chain Reaction · Risk Factors · RNA, Messenger · Thalidomide · Treatment Outcome · Tumor Necrosis Factor-alpha · Up-Regulation · Animalia · Mus musculus
[Abstract]

Search results also available in MS Excel format.

Showing 1 to 11 of 11 found. | Sort by date